<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Explaining The Rationale Of My GERN &#8211; GERON Position</title>
	<atom:link href="http://www.tischendorf.com/2009/01/31/explaining-the-rationale-of-my-gern-geron-position/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.tischendorf.com/2009/01/31/explaining-the-rationale-of-my-gern-geron-position/</link>
	<description>Trading High Potential Stocks</description>
	<lastBuildDate>Fri, 13 Jan 2012 03:26:12 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.2.1</generator>
	<item>
		<title>By: Markets Still Sending Conflicting Signals</title>
		<link>http://www.tischendorf.com/2009/01/31/explaining-the-rationale-of-my-gern-geron-position/comment-page-1/#comment-52</link>
		<dc:creator>Markets Still Sending Conflicting Signals</dc:creator>
		<pubDate>Sun, 01 Aug 2010 04:50:04 +0000</pubDate>
		<guid isPermaLink="false">http://www.tischendorf.com/?p=371#comment-52</guid>
		<description>[...] GERN &#8211; Geron Corp. got an FDA approval. Risk appetite is still there and with the recent GERN move one could say it is increasing significantly as GERN is arguably one of the more speculative stocks out there. Biotech stocks and especially stem cell stocks are definitely not for the faint of heart. Still, I like to monitor the sector as it helps gauge traders&#8217; risk appetite. [...]</description>
		<content:encoded><![CDATA[<p>[...] GERN &#8211; Geron Corp. got an FDA approval. Risk appetite is still there and with the recent GERN move one could say it is increasing significantly as GERN is arguably one of the more speculative stocks out there. Biotech stocks and especially stem cell stocks are definitely not for the faint of heart. Still, I like to monitor the sector as it helps gauge traders&#8217; risk appetite. [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Stem Cell Plays And Why I Prefer Geron &#8211; GERN</title>
		<link>http://www.tischendorf.com/2009/01/31/explaining-the-rationale-of-my-gern-geron-position/comment-page-1/#comment-51</link>
		<dc:creator>Stem Cell Plays And Why I Prefer Geron &#8211; GERN</dc:creator>
		<pubDate>Wed, 21 Oct 2009 05:20:11 +0000</pubDate>
		<guid isPermaLink="false">http://www.tischendorf.com/?p=371#comment-51</guid>
		<description>[...] people started asking me if I follow other stem cell stocks and why I prefer GERN &#8211; Geron. So I decided to add &#8216;Sector Overview Charts&#8217;. More will follow. Stay [...]</description>
		<content:encoded><![CDATA[<p>[...] people started asking me if I follow other stem cell stocks and why I prefer GERN &#8211; Geron. So I decided to add &#8216;Sector Overview Charts&#8217;. More will follow. Stay [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Sector Overview Chart Lists</title>
		<link>http://www.tischendorf.com/2009/01/31/explaining-the-rationale-of-my-gern-geron-position/comment-page-1/#comment-50</link>
		<dc:creator>Sector Overview Chart Lists</dc:creator>
		<pubDate>Fri, 17 Jul 2009 15:08:28 +0000</pubDate>
		<guid isPermaLink="false">http://www.tischendorf.com/?p=371#comment-50</guid>
		<description>[...] Stem Cells [...]</description>
		<content:encoded><![CDATA[<p>[...] Stem Cells [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>

